Table 2 Baseline data differences between the study group and the conventional group [(x̅ ± s), n(%)]
factors | Conventional group | Study group | t/x2 | P |
|---|---|---|---|---|
age | 50.61 ± 10.79 | 64.41 ± 9.77 | -13.42 | < 0.001 |
male/female(n/n) | 164/100 | 97/70 | 0.698 | 0.403 |
BMI, Mean ± SD | 19.81 ± 2.26 | 23.15 ± 5.05 | -9.369 | < 0.001 |
Duration of T2DM (years, Mean ± SD) | 5.16 ± 1.02 | 8.16 ± 1.32 | -26.489 | < 0.001 |
Peripheral vascular disease, n(%) | 171(64.77) | 145(86.83) | 25.432 | < 0.001 |
Peripheral neuropathy, n(%) | 118(44.70) | 83(49.70) | 1.029 | 0.31 |
Diabetic nephropathy, n(%) | 46(17.42) | 37(22.16) | 1.473 | 0.225 |
hypertention, n(%) | 122(46.21) | 103(61.68) | 9.804 | 0.002 |
Fatty liver, n(%) | 121(45.45) | 102(61.08) | 9.52 | 0.002 |